Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...

In the United States, the Shield MCD test has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) based on its strong performance in predicting the presence of ...

After a routine blood test led to his diagnosis, the 70-year-old travel expert urges everyone to prioritize health exams.

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

Nairobi is currently the epicenter of Kenya's cancer crisis, accounting for 13 percent of all reported cases nationwide. As the country's primary medical hub, the city's health sy ...

The future of medicine has arrived, and it brings with it a lot of confusion. From tests to supplements, dietary and exercise advice, it is often difficult to know how to use new medical ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...

How being a mother helped me through cancer - FIRST PERSON: On Mother’s Day, Clare Berry describes how her husband and two daughters carried her through eight months of dealing with cancer and reveals ...

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. As a ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsMartin Hogan - Senior Director ...